Neuropathies Associated with Renal Failure, Hepatic Disorders, Chronic Respiratory Disease, and Critical Illness

Peripheral Neuropathy

Volumn 2, Issue , 2005, Pages 2017-2037

  Zochodne, Douglas W ^a  

^a FOOTHILLS HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34547532743     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7216-9491-7.50090-9     Document Type: Chapter

References (223)

1. Ackil A.A., Shahani B.T., Young R.R. Sural nerve conduction studies and late responses in children undergoing hemodialysis. Arch. Phys. Med. Rehabil. 1981, 62:487.
2. Ackil A.A., Shahani B.T., Young R.R., Rubin N.E. Late response and sural conduction studies: usefulness in patients with chronic renal failure. Arch. Neurol. 1981, 38:482.
3. Agusti A.G., Torres A., Estopa R., Agustividal A. Hypophosphatemia as a cause of failed weaning: the importance of metabolic factors. Crit. Care Med. 1984, 12:142.
4. Alonso Alonso P., Chicharro F., Lopez-Messa J.B., et al. Critically ill polyneuropathy. Crit. Care Med. 1987, 15:1162.
5. Appenzeller O., Kornfeld M., Snyder R. Acromutila-ting, paralyzing neuropathy with corneal ulceration in Navajo children. Arch. Neurol. 1976, 33:733.
6. Appenzeller O., Parks R.D., MacGee J. Peripheral neuropathy in chronic disease of the respiratory tract. Am. J. Med. 1968, 44:873.
7. Arbus G.S., Barnor N.A., Hsu A.C., et al. Effect of chronic renal failure, dialysis and transplantation on motor nerve conduction velocity in children. Can. Med. Assoc. J. 1975, 113:517.
8. Asaba H., Alvestrand A., Furst P., Bergstrom J. Clinical implications of uremic middle molecules in regular hemodialysis patients. Clin. Nephrol. 1983, 19:179.
9. Asbury A.K. Neuropathies with renal failure, hepatic disorders, chronic respiratory insufficiency and critical illness. Peripheral Neuropathy 1993, 1251. W. B. Saunders, Philadelphia. 3rd ed. P.J. Dyck, P.K. Thomas, J.W. Griffin (Eds.).
10. Asbury A.K., Victor M., Adams R.D. Uremic polyneuropathy. Trans. Am. Neurol. Assoc. 1962, 87:100.
11. Asbury A.K., Victor M., Adams R.D. Uremic polyneuropathy. Arch. Neurol. 1963, 8:413.
12. Babb A.L., Popovich R.P., Christopher T.G., Scribner B.H. The genesis of the square meter-hour hypothesis. Trans. Am. Soc. Artif. Intern. Organs 1971, 17:81.
13. Bach C., Iaina A., Eliahou H.E. Autonomic nervous system disturbance in patients on chronic hemodialysis. Isr. J. Med. Sci. 1979, 9:761.
14. Baracos V., Rodemann H.P., Dinarello C.A., Goldberg A.L. Stimulation of muscle protein degradation and prostaglandin E2 release by leGBRocytic pyrogen (interleGBRin-1): a mechanism for the increased degradation of muscle proteins during fever. N. Engl. J. Med. 1983, 308:553.
15. Bazzi C., Pagani C., Sorgato G., et al. Uremic polyneuropathy: a clinical and electrophysiological study in 135 short- and long-term hemodialyzed patients. Clin. Nephrol. 1991, 35:176.
16. Benjamin E., Leibowitz A.B., Oropello J., Iberti T.J. Systemic hypoxic and inflammatory syndrome: an alternative designation for "sepsis syndrome." Crit. Care Med. 1992, 20:680.
17. Benstead T.J., Dyck P.J., Low P. Chronic hypoxia induces selective maldevelopment of peripheral myelin in rat. J. Neuropathol. Exp. Neurol. 1988, 47:599.
18. Berkompas R.J. A case of peripheral neuropathy and hepatitis. J. Tenn. Med. Assoc. 1990, 83:191.
19. Blumberg A., Burgi W. Behavior of beta 2-microglobulin in patients with chronic renal failure undergoing hemodialysis, hemodiafiltration and continuous ambulatory peritoneal dialysis (CAPD). Clin. Nephrol. 1987, 27:245.
20. Bolton C.F. Electrophysiologic changes in uremic neuropathy after successful renal transplantation. Neurology 1976, 26:152.
21. Bolton C.F. Peripheral neuropathies associated with chronic renal failure. Can. J. Neurol. Sci. 1980, 7:89.
22. Bolton C.F., Baltzan M.A., Baltzan R.B. Effects of renal transplantation on uremic neuropathy: a clinical and electrophysiologic study. N. Engl. J. Med. 1971, 284:1170.
23. Bolton C.F., Driedger A.A., Lindsay R.M. Ischaemic neuropathy in uraemic patients caused by bovine arteriovenous shunt. J. Neurol. Neurosurg. Psychiatry 1979, 42:810.
24. Bolton C.F., Gilbert J.J., Hahn A.F., Sibbald W.J. Polyneuropathy in critically ill patients. J. Neurol. Neurosurg. Psychiatry 1984, 47:1223.
25. Bolton C.F., Laverty D.A., Brown J.D., et al. Critically ill polyneuropathy: electrophysiological studies and differentiation from Guillain-Barre syndrome. J. Neurol. Neurosurg. Psychiatry 1986, 49:563.
26. Bolton C.F., McKeown M.J., Chen R., et al. Subacute uremic and diabetic polyneuropathy. Muscle Nerve 1997, 20:59.
27. Bolton C.F., Remtulla H., Toth B., et al. Distinctive electrophysiological features of denervated muscle in uremic patients. J. Clin. Neurophysiol. 1997, 14:539.
28. Bolton C.F., Young G.B. Neurological Complications of Renal Disease 1990, Butterworths, Boston.
29. Bolton C.F., Young G.B., Zochodne D.W. Neurological changes during severe sepsis. Current Topics in Intensive Care 1994, 180. W. B. Saunders, London. G. Dobb, J. Bion, H. Bjardhi, R.P. Billinger (Eds.).
30. Bone R.C. Leťs agree on terminology: definitions of sepsis. Crit. Care Med. 1991, 19:973.
31. Bone R.C. The sepsis syndrome: definition and general approach to management. Clin. Chest Med. 1996, 17:175.
32. Bonetti B., Scardoni M., Monaco S., et al. Hepatitis C virus infection of peripheral nerves in type II cryoglobulinaemia. Virchows Arch. 1999, 434:533.
33. Botella J., Gea T., Sanz-Guajardo D., et al. Blood levels of middle molecules and their effects on motor nerve conduction velocity. Artif. Organs 1981, 4(Suppl.):151.
34. Boudet J., Man N.K., Cueille G., et al. Relationship between plasma concentration of middle molecular weight fraction b, motor nerve conduction velocity, and plasma creatinine in experimental chronic renal failure rats. Artif. Organs 1981, 4(Suppl.):115.
35. Braguer D., Chauvet-Monges A.M., Sari J.C., et al. Inhibition in vitro of the polymerization of tubulin by uremic middle molecules: corrective effect of isaxonine. Clin. Nephrol. 1983, 20:149.
36. Bredt D.S. Targeting nitric oxide to its targets. Proc. Soc. Exp. Biol. Med. 1996, 211:41.
37. Bredt D.S., Snyder S.H. Nitric oxide: a physiologic messenger molecule. Annu. Rev. Biochem. 1994, 63:175.
38. Brismar T. Changes in electrical threshold in human peripheral neuropathy. J. Neurol. Sci. 1985, 68:215.
39. Cacoub P., Maisonobe T., Thibault V., et al. Systemic vasculitis in patients with hepatitis C. J. Rheumatol. 2001, 28:109.
40. Campese V.M., Romoff M.S., Levitan D., et al. Mechanisms of autonomic nervous system dysfunction in uremia. Kidney Int. 1981, 20:246.
41. Caniatti L.M., Tugnoli V., Eleopra R., et al. Cryoglobulinemic neuropathy related to hepatitis C virus infection: clinical, laboratory and neurophysiological study. J. Peripher. Nerv. Syst. 1996, 1:131.
42. Castaigne P., Cathala H.P., Beaussart-Boulenge L., Petrover M. Effect of ischaemia on peripheral nerve function in patients with chronic renal failure undergoing dialysis treatment. J. Neurol. Neurosurg. Psychiatry 1972, 35:631.
43. Chandran A.P., Singal K.K., Mahajan S.K., et al. H-reflex latency and sensory conduction in the assessment of neuropathy in patients of chronic obstructive lung disease. Electromyogr. Clin. Neurophysiol. 1991, 31:99.
44. Charra B., Calemard E., Uzan M., et al. Carpal tunnel syndrome, shoulder pain and amyloid deposits in long-term haemodialysis patients. Proc. Eur. Dial. Transplant Assoc. Eur. Ren. Assoc. 1985, 21:291.
45. Charron L., Peyronnard J.M., Marchand L. Sensory neuropathy associated with primary biliary cirrhosis: histologic and morphometric studies. Arch. Neurol. 1980, 37:84.
46. Chaudhry V., Corse A.M., O'Brian R., et al. Autonomic and peripheral (sensorimotor) neuropathy in chronic liver disease: a clinical and electrophysiologic study. Hepatology 1999, 29:1698.
47. Clowes G.H., George B.C., Villee C.A., Saravis C.A. Muscle proteolysis induced by a circulating peptide in patients with sepsis or trauma. N. Engl. J. Med. 1983, 308:545.
48. Danon M.J., Carpenter S. Myopathy with thick filament (myosin) loss following prolonged paralysis with vecuronium during steroid treatment. Muscle Nerve 1991, 14:1131.
49. Del Giudice G., Galli M., Chemotti M., et al. Brachial paresis complicating acute non-A, non-B hepatitis. Boll. Ist. Sieroter. Milan 1984, 63:499.
50. Dyck P.J. Hypoxic neuropathy: does hypoxia play a role in diabetic neuropathy? The 1988 Robert Wartenberg lecture. Neurology 1989, 39:111.
51. Dyck P.J., Johnson W.J., Lambert E.H., O'Brien P.C. Segmental demyelination secondary to axonal degeneration in uremic neuropathy. Mayo Clin. Proc. 1971, 46:400.
52. Dyck P.J., Johnson W.J., Lambert E.H., et al. Comparison of symptoms, chemistry and nerve function to assess adequacy of hemodialysis. Neurology 1979, 29:1361.
53. Eliasson M.J., Huang Z., Ferrante R.J., et al. Neuronal nitric oxide synthase activation and peroxynitrite formation in ischemic stroke linked to neural damage. J. Neurosci. 1999, 19:5910.
54. Ewing D.J., Winney R. Autonomic function in patients with chronic renal failure on intermittent haemodialysis. Nephron 1975, 15:424.
55. Faden A., Mendoza E., Flynn F. Subclinical neuropathy associated with chronic obstructive pulmonary disease. Arch. Neurol. 1981, 38:639.
56. Fink M.P. Prostaglandins and sepsis: still a fascinating topic despite almost 40 years of research. Am. J. Physiol. Lung Cell. Mol. Physiol. 2001, 281:L534.
57. Fleckenstein J.F., Frank S., Thuluvath P.J. Presence of autonomic neuropathy is a poor prognostic indicator in patients with advanced liver disease. Hepatology 1996, 23:471.
58. Fry D.E. Multiple system organ failure. Surg. Clin. North. Am. 1988, 68:107.
59. Ganji S., Mahajan S. Changes in short-latency somatosensory evoked potentials during hemodialysis in chronic renal failure. Clin. Electroencephalogr. 1983, 14:202.
60. Gejyo F., Homma N., SuzGBRi Y., Arakawa M. Serum levels of beta 2-microglobulin as a new form of amyloid protein in patients undergoing long-term hemodialysis. N. Engl. J. Med. 1986, 314:585.
61. Goldberg A.L., Baracos V., Rodemann P., et al. Control of protein degradation in muscle by prostaglandins, Ca2+ and leGBRocytic pyrogen (interleGBRin 1). Fed. Proc. 1984, 43:1301.
62. Gonin J.M., Kadrofske M.M., Schmaltz S., et al. Corrected Q-T interval prolongation as diagnostic tool for assessment of cardiac autonomic neuropathy in diabetes mellitus. Diabetes Care 1990, 13:68.
63. Gorson K.C., Ropper A.H. Acute respiratory failure neuropathy: a variant of critical illness polyneuropathy. Crit. Care Med. 1993, 21:267.
64. Gulati P.D., Goel M.K., Kalra J.M., et al. Autonomic neuropathy in chronic uraemics. J. Indian Med. Assoc. 1980, 74:45.
65. Haupt M.T., Balaan M.R., Barber M.E., Carlson R. Effects of serum of patients with advanced sepsis on mitochondrial metabolism. Am. Rev. Respir. Dis. 1987, 135:A83.
66. Heckmann J.G., Kayser C., Heuss D., et al. Neurological manifestations of chronic hepatitis C. J. Neurol. 1999, 246:486.
67. Hegstrom R.M., Murray J.S., Pendras J.P., et al. Hemodialysis in the treatment of chronic uremia. Am. Soc. Artif. Intern. Organs 1961, 7:136.
68. Hegstrom R.M., Murray J.S., Pendras J.P., et al. Two year's experience with periodic hemodialysis in the treatment of chronic uremia. Am. Soc. Artif. Intern. Organs 1962, 8:266.
69. Helliwell T.R., Coakley J.H., Wagenmakers J.M., et al. Necrotizing myopathy in critically ill patients. J. Pathol. 1991, 164:307.
70. Henderson B., Koepke G.H., Feller I. Peripheral polyneuropathy among patients with burns. Arch. Phys. Med. Rehabil. 1971, 52:149.
71. Hendrickse M.T. QT interval, autonomic neuropathy, and alcoholic liver disease. Lancet 1993, 342:61.
72. Hendrickse M.T., Thuluvath P.J., Triger D.R. Natural history of autonomic neuropathy in chronic liver disease. Lancet 1992, 339:1462.
73. Hersch M., Troster M., Bersten A., et al. Histopathological evidence of tissue ischemia in a hyperdynamic and nonhypotensive septic animal model [abstract]. Crit. Care Med. 1988, 16:421.
74. Hess D.T., Patterson S.I., Smith D.S., Skene J.H. Neuronal growth cone collapse and inhibition of protein fatty acylation by nitric oxide. Nature 1993, 366:562.
75. Hirano M., Ott B.R., Raps E.C., et al. Acute quadriplegic myopathy: a complication of treatment with steroids, nondepolarizing blocking agents, or both. Neurology 1992, 42:2082.
76. Hoke A., Rewcastle N.B., Zochodne D.W. Acute quadriplegic myopathy unrelated to steroids or paralyzing agents: quantitative EMG studies. Can. J. Neurol. Sci. 1999, 26:325.
77. Holman R.T., Johnson S.B., Hatch T.F. A case of human linolenic acid deficiency involving neurological abnormalities. Am. J. Clin. Nutr. 1982, 35:617.
78. Holve S., Hu D., Shub M., et al. Liver disease in Navajo neuropathy. J. Pediatr. 1999, 135:482.
79. Hopkins I.J. A new syndrome: poliomyelitis-like illness associated with acute asthma in childhood. Aust. Paediatr. J. 1974, 10:273.
80. Hoshino S., Yoshizawa T., Hayashi A., et al. A combination of autoimmune hepatitis, sensory-dominant peripheral neuropathy, and primary Sjogren's syndrome in the same patient: a rare association. J. Med. 1999, 30:83.
81. Hund E.F., Fogel W., Krieger D., et al. Critical illness polyneuropathy: clinical findings and outcomes of a frequent cause of neuromuscular weaning failure. Crit. Care Med. 1996, 24:1328.
82. Illa I., Graus F., Ferrer I., Enriquez J. Sensory neuropathy as the initial manifestation of primary biliary cirrhosis. J. Neurol. Neurosurg. Psychiatry 1989, 52:1307.
83. Irioka T., Yamada M., Yamawaki M., et al. Acute autonomic and sensory neuropathy after interferon alpha-2b therapy for chronic hepatitis C. J. Neurol. Neurosurg. Psychiatry 2001, 70:408.
84. Jacobs D.O., Maris J., Fried R., et al. In vivo phosphorus 31 magnetic resonance spectroscopy of rat hind limb skeletal muscle during sepsis. Arch. Surg. 1988, 123:1425.
85. Jarratt J.A., Morgan C.N., Twomey J.A., et al. Neuropathy in chronic obstructive pulmonary disease: a multicentre electrophysiological and clinical study. Eur. Respir. J. 1992, 5:517.
86. Jeejeebhoy K.N., Chu R.C., Marliss E.B., et al. Chromium deficiency, glucose intolerance, and neuropathy reversed by chromium supplementation in a patient receiving long term total parenteral nutrition. Am. J. Clin. Nutr. 1977, 30:531.
87. Kaplan P.W., Rocha W., Sanders D.B., et al. Acute steroid-induced tetraplegia following status asthmaticus. Pediatrics 1986, 78:121.
88. Kardel T., Nielsen V.K. Hepatic neuropathy: a clinical and electrophysiological study. Acta Neurol. Scand. 1974, 50:513.
89. Kempler P., Varadi A., Kadar E., Szalay F. Autonomic and peripheral neuropathy in primary biliary cirrhosis: evidence of small sensory fibre damage and prolongation of the QT interval. J. Hepatol. 1994, 21:1150.
90. Kempler P., Varadi A., Szalay F. Autonomic neuropathy and prolongation of QT-interval in liver disease. Lancet 1992, 340:318.
91. Kersh E.S., Kronfield S.J., Unger A., et al. Autonomic insufficiency in uremia as a cause of hemodialysis-induced hypotension. N. Engl. J. Med. 1974, 290:650.
92. Khella S.L., Frost S., Hermann G.A., et al. Hepatitis C infection, cryoglobulinemia, and vasculitic neuropathy: treatment with interferon alfa: case report and literature review. Neurology 1995, 45:407.
93. Knezevic W., Mastaglia F.L. Neuropathy associated with Brescia-Cimino arteriovenous fistulas. Arch. Neurol. 1984, 41:1184.
94. Koch K.M., Baldamus C.A., Ernst W., et al. Autonomic circulatory regulation in uremia [in German]. Klin. Wochenschr. 1980, 58:1037.
95. Konishi T., Nishitani H., Motomura S. Single fiber electromyography in chronic renal failure. Muscle Nerve 1982, 5:458.
96. Korthals J.K., Wisniewski H.M. Peripheral nerve ischemia. Part 1. Experimental model. J. Neurol. Sci. 1975, 24:65.
97. Kumegawa M., Hiramatsu M., Yamada T., Yajima T. Effects of intermediate-sized molecular components in uremic sera on nerve tissues in vitro. Brain Res. 1980, 198:234.
98. La Civita L., Pasero G., Ferri C. Drs. La Civita, Pasero, and Ferri reply. J. Rheumatol. 1997, 24:1656.
99. La Civita L., Zignego A.L., Lombardini F., et al. Exacerbation of peripheral neuropathy during alpha-interferon therapy in a patient with mixed cryoglobulinemia and hepatitis B virus infection. J. Rheumatol. 1996, 23:1641.
100. Lacaille F., Zylberberg H., Hagege H., et al. Hepatitis C associated with Guillain-Barre syndrome. Liver 1998, 18:49.
101. Lacomis D., Giuliani M.J., Van Cott A., Kramer D.J. Acute myopathy of intensive care: clinical, electromyographic, and pathological aspects. Ann. Neurol. 1996, 40:645.
102. Lacomis D., Petrella T., Giuliani M.J. Causes of neuromuscular weakness in the intensive care unit: a study of ninety-two patients. Muscle Nerve 1998, 21:610.
103. Lacomis D., Smith T.W., Chad D.A. Acute myopathy and neuropathy in status asthmaticus: case report and literature review. Muscle Nerve 1993, 16:84.
104. Lacomis D., Zochodne D.W., Bird S.J. Critical illness myopathy. Muscle Nerve 2000, 23:1785.
105. Landry D.W., Oliver J.A. The pathogenesis of vasodila-tory shock. N. Engl. J. Med. 2001, 345:588.
106. Larsson L., Li X., Edstrom L., et al. Acute quadriplegia and loss of muscle myosin in patients treated with nondepolarizing neuromuscular blocking agents and corticosteroids: mechanisms at the cellular and molecular levels. Crit. Care Med. 2000, 28:34.
107. Leijten F.S.S., de Weerd A. Critical illness polyneuropathy, facts and controversies. J. Peripher. Nerv. Syst. 1996, 1:28.
108. Levitan D., Massry S.G., Romoff M.S., Campese V.M. Autonomic nervous system dysfunction in patients with acute renal failure. Am. J. Nephrol. 1982, 2:213.
109. Levy D., Hoke A., Zochodne D.W. Local expression of inducible nitric oxide synthase in an animal model of neuropathic pain. Neurosci. Lett. 1999, 260:207.
110. Levy D., Tal M., Hoke A., Zochodne D.W. Transient action of the endothelial constitutive nitric oxide synthase (ecNOS) mediates the development of thermal hypersensitivity following peripheral nerve injury. Eur. J. Neurosci. 2000, 12:2323.
111. Levy D., Zochodne D.W. Local nitric oxide synthase activity in a model of neuropathic pain. Eur. J. Neurosci. 1998, 10:1846.
112. Lewis E.G., Dustman R.E., Beck E.C. Visual and somatosensory evoked potentials characteristics of patients undergoing hemodialysis and kidney transplantation. Electroencephalogr. Clin. Neurophysiol. 1978, 44:223.
113. Lidove O., Cacoub P., Maisonobe T., et al. Hepatitis C virus infection with peripheral neuropathy is not always associated with cryoglobulinaemia. Ann. Rheum. Dis. 2001, 60:290.
114. Liedholm L.J.A., Eeg-Olofsson O., Ekenberg B.E.K., et al. Acute postasthmatic amyotrophy (Hopkins' syndrome). Muscle Nerve 1994, 17:769.
115. Lindsay R.M., Bolton C.F., Clark W.F., Linton A.L. The effect of alterations of uremic retention products upon platelet and peripheral nerve function. Clin. Nephrol. 1983, 19:110.
116. Low P.A., Lagerlund T.D., McManis P.G. Nerve blood flow and oxygen delivery in normal, diabetic, and ischemic neuropathy. Int. Rev. Neurobiol. 1989, 31:355.
117. Ludwig J., Dyck P.J., LaRusso N.F. Xanthomatous neuropathy of liver. Hum. Pathol. 1982, 13:1049.
118. Man N.K., Cueille G., Zingraff J., et al. Uremic neurotoxin in the middle molecular weight range. Artif. Organs 1980, 4:116.
119. Marin O.S.M., Tyler H.R. Hereditary interstitial nephritis associated with polyneuropathy [abstract]. Neurology 1961, 11:999.
120. Marquez S., Turley J.J.E., Peters W.J. Neuropathy in burn patients. Brain 1993, 116:471.
121. Mayer P., Dematteis M., Pepin J.L., et al. Peripheral neuropathy in sleep apnea: a tissue marker of the severity of nocturnal desaturation. Am. J. Respir. Crit. Care Med. 1999, 159:213.
122. McDonald T.J., Zincke H., Anderson C.F., Ott N.T. Reversal of deafness after renal transplantation in Alport's syndrome. Laryngoscope 1978, 88:38.
123. McQuillen M.P., Cantor H.E., O'Rourke J.R. Myasthenic syndrome associated with antibiotics. Arch. Neurol. 1968, 18:402.
124. Mendez P., Saeian K., Reddy K.R., et al. Hepatitis C, cryoglobulinemia, and cutaneous vasculitis associated with unusual and serious manifestations. Am. J. Gastroenterol. 2001, 96:2489.
125. Min J.K., Park K.S., Yu W.J., et al. Systemic mononuclear inflammatory vasculopathy associated with Sjogren's syndrome in a patient with primary biliary cirrhosis. Korean J. Intern. Med. 2000, 15:89.
126. Minetti C., Hirano M., Morreale G., et al. Ubiquitin expression in acute steroid myopathy with loss of myosin thick filaments. Muscle Nerve 1996, 19:94.
127. Mitschke H., Schmidt P., Kopsa H., Zazgornik J. Reversible uremic deafness after successful renal transplantation. N. Engl. J. Med. 1975, 292:1062.
128. Moore N., Lerebours G., Senant J., et al. Peripheral neuropathy in chronic obstructive lung disease. Lancet 1985, 2:1311.
129. Naik R.B., Mathias C.J., Wilson C.A., et al. Cardiovascular and autonomic reflexes in haemodialysis patients. Clin. Sci. 1981, 60:165.
130. Narayan M., Ferranti R. Nerve conduction impairment in patients with respiratory insufficiency and severe chronic hypoxemia. Arch. Phys. Med. Rehabil. 1978, 59:188.
131. Newrick P.G., Wilson A.J., Jakubowski J., et al. Sural nerve oxygen tension in diabetes. Br. Med. J. (Clin. Res. Ed.) 1986, 293:1053.
132. Nielsen V.K. The peripheral nerve function in chronic renal failure. II. Intercorrelation of clinical symptoms and signs and clinical grading of neuropathy. Acta Med. Scand. 1971, 190:113.
133. Nielsen V.K. The peripheral nerve function in chronic renal failure. IV. An analysis of the vibratory perception threshold. Acta Med. Scand. 1972, 191:287.
134. Nielsen V.K. The peripheral nerve function in chronic renal failure. V. Sensory and motor conduction velocity. Acta Med. Scand. 1973, 194:445.
135. Nielsen V.K. The peripheral nerve function in chronic renal failure. VI. The relationship between sensory and motor nerve conduction and kidney function, azotemia, age, sex, and clinical neuropathy. Acta Med. Scand. 1973, 194:455.
136. Nielsen V.K. The peripheral nerve function in chronic renal failure. VII. Longitudinal course during terminal renal failure and regular hemodialysis. Acta Med. Scand. 1974, 195:155.
137. Nielsen V.K. The peripheral nerve function in chronic renal failure. VIII. Recovery after renal transplantation: clinical aspects. Acta Med. Scand. 1974, 195:163.
138. Nies A.S., Robertson D., Stone W.J. Hemodialysis hypotension is not the result of uremic peripheral autonomic neuropathy. J. Lab. Clin. Med. 1979, 94:395.
139. Nijeholt J.L.A., Troost J. Critical illness polyneuropathy. Neuropathies (Handbook of Clinical Neurology, rev. ser. 7, Vol. 51) 1987, 575. Elsevier, Amsterdam. P.J. Vinken, G.W. Bruyn, H.L. Klawans (Eds.).
140. Nowak D., Bruch M., Arnaud F., et al. Peripheral neuropathies in patients with chronic obstructive pulmonary disease: a multicenter prevalence study. Lung 1990, 168:43.
141. NGBRada H. Increased susceptibility to ischemic damage in streptozocin diabetic nerve. Diabetes 1986, 35:1058.
142. NGBRada H., Dyck P.J. Microsphere embolization of nerve capillaries and fiber degeneration. Am. J. Pathol. 1984, 115:275.
143. NGBRada H., Dyck P.J., Karnes J.L. Spatial distribution of capillaries in rat nerves: correlation to ischemic damage. Exp. Neurol. 1985, 87:369.
144. Obeso J.A., Marti-Masso J.F., Asin J.L., et al. Conduction velocity through the somesthetic pathway in chronic renal failure. J. Neurol. Sci. 1979, 43:439.
145. Op de Coul A.A.W., Lambregts P.C.L.A., Koeman J., et al. Neuromuscular complications in patients given Pavulon (pancuronium bromide) during artificial ventilation. Clin. Neurol. Neurosurg. 1985, 87:17.
146. Ozge A., Atis S., Sevim S. Subclinical peripheral neuropathy associated with chronic obstructive pulmonary disease. Electromyogr. Clin. Neurophysiol. 2001, 41:185.
147. Panayiotopoulos C.P., Lagos G. Tibial nerve H-reflex and F-wave studies in patients with uremic neuropathy. Muscle Nerve 1980, 3:423.
148. Panayiotopoulos C.P., Scarpalezos S. F-wave studies on the deep peroneal nerve. Part 2.-1. Chronic renal failure. 2. Limb-girdle muscular dystrophy. J. Neurol. Sci. 1977, 31:331.
149. Paolino E., Granieri E., Tugnoli V. Peripheral neuropathy as a manifestation of hydatid disease: a case report. Acta Neurol. Scand. 1987, 9:256.
150. Paramelle B., Vila A., Pollak P., et al. Incidence of polyneuropathies in chronic obstructive bronchopneumopathies. Presse Med. 1986, 15:563.
151. Parratt J.R. Nitric oxide in sepsis and endotoxaemia. J. Antimicrob. Chemother. 1998, 41(Suppl. A):31.
152. Parry G.J., Brown M.J. Arachidonate-induced experimental nerve infarction. J. Neurol. Sci. 1981, 50:123.
153. Pentschew A., Schwarz K. Systemic axonal dystrophy in vitamin E deficient adult rats: with implication in human neuropathology. Acta Neuropathol. 1962, 1:313.
154. Perretti A., Gentile S., Balbi P., et al. Peripheral neuropathy in liver cirrhosis: a clinical and electrophysiological study. Ital. J. Gastroenterol. 1995, 27:349.
155. Pfeiffer G., Kunze K., Bruch M., et al. Polyneuropathy associated with chronic hypoxaemia: prevalence in patients with chronic obstructive pulmonary disease. J. Neurol. 1990, 237:230.
156. Pugh R.N., Murray-Lyon I.M., Dawson J.L., et al. Transection of the oesophagus for bleeding oesophageal varices. Br. J. Surg. 1973, 60:646.
157. Quick C.A. Hearing loss in patients with dialysis and renal transplants. Ann. Otol. Rhinol. Laryngol. 1976, 85:776.
158. Ramsay D.A., Zochodne D.W., Robertson D.M., et al. A syndrome of acute severe muscle necrosis in intensive care unit patients. J. Neuropathol. Exp. Neurol. 1993, 52:387.
159. Raskin N.H., Fishman R.A. Neurologic disorders in renal failure (second of two parts). N. Engl. J. Med. 1976, 294:204.
160. Read D.J., Feest T.G., Holman R.H. Vibration sensory threshold: a guide to adequacy of dialysis? Proc. Eur. Dial. Transplant Assoc. 1983, 19:253.
161. Redford E.J., Kapoor R., Smith K.J. Nitric oxide donors reversibly block axonal conduction: demyelinated axons are especially susceptible. Brain 1997, 120:2149.
162. Rich M.M., Raps E.C., Bird S.J. Distinction between acute myopathy syndrome and critical illness polyneuropathy. Mayo Clin. Proc. 1995, 70:198.
163. Ripault M.P., Borderie C., Dumas P., et al. Peripheral neuropathies and chronic hepatitis C.: a frequent association?. [in French]. Gastroenterol. Clin. Biol. 1998, 22:891.
164. Rockel A., Hennemann H., Sternagel-Haase A., Heidland A. Uraemic sympathetic neuropathy after haemodialysis and transplantation. Eur. J. Clin. Invest. 1979, 9:23.
165. Ropper A.H. Accelerated neuropathy of renal failure. Arch. Neurol. 1993, 50:536.
166. Rosenblum J.L., Keating J.P., Prensky A.L., Nelson J.S. A progressive neurologic syndrome in children with chronic liver disease. N. Engl. J. Med. 1981, 304:503.
167. Rossini P.M., Treviso M., Di Stefano E., Di Paolo B. Nervous impulse propagation along peripheral and central fibres in patients with chronic renal failure. Electroencephalogr. Clin. Neurophysiol. 1983, 56:293.
168. Said G., Boudier L., Selva J., et al. Different patterns of uremic polyneuropathy: clinicopathologic study. Neurology 1983, 33:567.
169. Satya-Murti S., Howard L., Krohel G., Wolf B. The spectrum of neurologic disorder from vitamin E deficiency. Neurology 1986, 36:917.
170. Savazzi G.M., Buzio C., Migone L. Lights and shadows on the pathogenesis of uremic polyneuropathy. Clin. Nephrol. 1982, 18:219.
171. Schmelzer J.D., Zochodne D.W., Low P.A. Ischemic and reperfusion injury of rat peripheral nerve. Proc. Natl. Acad. Sci. U. S. A. 1989, 86:1639.
172. Sheth R.D., Bolton C.F. Neuromuscular complications of sepsis in children. J. Child Neurol. 1995, 10:346.
173. Singleton R., Helgerson S.D., Snyder R.D., et al. Neuropathy in Navajo children: clinical and epidemiologic features. Neurology 1990, 40:363.
174. Sitwell L.D., Weinshenker B.G., Monpetit V., Reid D. Complete ophthalmoplegia as a complication of acute corticosteroid and pancuronium associated myopathy. Neurology 1991, 41:921.
175. Sladky J.T., Tschoepe R.L., Greenberg J.H., Brown M.J. Peripheral neuropathy after chronic endoneurial ischemia. Ann. Neurol. 1991, 29:272.
176. Smith K.J., Kapoor R., Hall S.M., Davies M. Electrically active axons degenerate when exposed to nitric oxide. Ann. Neurol. 2001, 49:470.
177. Sokol R.J., Guggenheim M.A., Heubi J.E., et al. Frequency and clinical progression of the vitamin E deficiency neurologic disorder in children with prolonged neonatal cholestasis. Am. J. Dis. Child. 1985, 139:1211.
178. Sokol R.J., Guggenheim M.A., Iannaccone S.T., et al. Improved neurologic function after long-term correction of vitamin E deficiency in children with chronic cholestasis. N. Engl. J. Med. 1985, 313:1580.
179. Solders G., Persson A., Gutierrez A. Autonomic dysfunction in non-diabetic terminal uraemia. Acta Neurol. Scand. 1985, 71:321.
180. Solders G., Persson A., Wilczek H. Autonomic system dysfunction and polyneuropathy in nondiabetic uremia: a one-year follow-up study after renal transplantation. Transplantation 1986, 41:616.
181. Solders G., Wilczek H., Gunnarsson R., et al. Effects of combined pancreatic and renal transplantation on diabetic neuropathy: a two-year follow-up study. Lancet 1987, 2:1232.
182. Soriano G., Eisinger R.P. Abnormal response to the Valsalva maneuver in patients on chronic hemodialysis. Nephron 1972, 9:251.
183. Stewart A.G., Waterhouse J.C., Howard P. The QTc interval, autonomic neuropathy and mortality in hypoxaemic COPD. Respir. Med. 1995, 89:79.
184. Stoebner P., Mezin P., Vila A., et al. Microangiopathy of endoneurial vessels in hypoxemic chronic obstructive pulmonary disease (COPD): a quantitative ultrastructural study. Acta Neuropathol. 1989, 78:388.
185. Sung J.H., Park S.H., Mastri A.R., Warwick W.J. Axonal dystrophy in the gracile nucleus in congenital biliary atresia and cystic fibrosis (mucoviscidosis): beneficial effect of vitamin E therapy. J. Neuropathol. Exp. Neurol. 1980, 39:584.
186. SuzGBRi H., Takei T., Tsuji H., Nishikawa T. Membranoproliferative glomerulonephritis and demyelinating neuropathy caused by type II mixed cryoglobulinemia associated with HCV infection. Intern. Med. 2000, 39:397.
187. Tambini R., Quattrini A., Fracassetti O., Nemni R. Axonal neuropathy in a patient receiving interferon-alpha therapy for chronic hepatitis C. J. Rheumatol. 1997, 24:1656.
188. Tegner R., Brismar T. Experimental uremic neuropathy. Part 1. Decreased nerve conduction velocity in rats. J. Neurol. Sci. 1984, 65:29.
189. Tegner R., Lindholm B. Uremic polyneuropathy: different effects of hemodialysis and continuous ambulatory peritoneal dialysis. Acta Med. Scand. 1985, 218:409.
190. Tegner R., Lindholm B. Vibratory perception threshold compared with nerve conduction velocity in the evaluation of uremic neuropathy. Acta Neurol. Scand. 1985, 71:284.
191. Tembl J.I., Ferrer J.M., Sevilla M.T., et al. Neurologic complications associated with hepatitis C virus infection. Neurology 1999, 53:861.
192. Thiele B., Stalberg E. Single fibre EMG findings in polyneuropathies of different aetiology. J. Neurol. Neurosurg. Psychiatry 1975, 38:881.
193. Thomas P.K., Walker J.G. Xanthomatous neuropathy in primary biliary cirrhosis. Brain 1965, 88:1079.
194. Thuluvath P.J., Triger D.R. Autonomic neuropathy and chronic liver disease. Q. J. Med. 1989, 72:737.
195. Traber M.G., Sokol R.J., Ringel S.P., et al. Lack of tocopherol in peripheral nerves of vitamin E-deficient patients with peripheral neuropathy. N. Engl. J. Med. 1987, 317:262.
196. Trevisani F., Sica G., Bernardi M. Autonomic neuropathy in advanced liver disease. Hepatology 1996, 24:1549.
197. TsGBRada N., Koh C.S., Inoue A., Yanagisawa N. Demyelinating neuropathy associated with hepatitis B virus infection: detection of immune complexes composed of hepatitis B virus surface antigen. J. Neurol. Sci. 1987, 77:203.
198. TsGBRada N., Koh C.S., Owa M., Yanagisawa N. Chronic neuropathy associated with immune complexes of hepatitis B virus. J. Neurol. Sci. 1983, 61:193.
199. Tuck R.R., Schmelzer J.D., Low P.A. Endoneurial blood flow and oxygen tension in the sciatic nerves of rats with experimental diabetic neuropathy. Brain 1984, 107:935.
200. Valli G., Barbieri S., Sergi P., et al. Evidence of motor neuron involvement in chronic respiratory sufficiency. J. Neurol. Neurosurg. Psychiatry 1984, 47:1117.
201. Van Der Vliet J.A., Navarro X., Kennedy W.R., et al. Long-term follow-up of polyneuropathy in diabetic kidney transplant recipients. Diabetes 1988, 37:1247.
202. Vaziri D., Pratt H., Saiki J.K., Starr A. Evaluation of somatosensory pathway by short latency evoked potentials in patients with end-stage renal disease maintained on hemodialysis. Int. J. Artif. Organs 1981, 4:17.
203. Verge V.M.K., Xu Z., Xu X.J., et al. Marked increase in nitric oxide synthase mRNA in rat dorsal root ganglia after peripheral axotomy: in situ hybridization and functional studies. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:11617.
204. Vita G., Savica V., Milone S., et al. Uremic autonomic neuropathy: recovery following bicarbonate hemodialysis. Clin. Nephrol. 1996, 45:56.
205. Wijdicks E.F.M., Litchy W.J., Harrison B.A., Gracey D.R. The clinical spectrum of critical illness polyneuropathy. Mayo Clin. Proc. 1994, 69:955.
206. Williams A.C., Sturman S., Kelsey S., et al. The neuropathy of the critically ill. Br. Med. J. (Clin. Res. Ed.) 1986, 293:790.
207. Witt N.J., Zochodne D.W., Bolton C.F., et al. Peripheral nerve function in sepsis and multiple organ failure. Chest 1991, 99:176.
208. Wright E.A., McQuillen M.P. Hypoexcitability of ulnar nerve in patients with normal motor nerve conduction velocities. Neurology 1973, 23:78.
209. Wytrzes L., Markley H.G., Fisher M., Alfred H.J. Brachial neuropathy after brachial artery-antecubital vein shunts for chronic hemodialysis. Neurology 1987, 37:1398.
210. Yashpal Issar U. Autonomic failure of circulation in chronic uremia. Indian J. Med. Sci. 1982, 36:69.
211. Yosipovitch G., Yarnitsky D., Mermelstein V., et al. Paradoxical heat sensation in uremic polyneuropathy. Muscle Nerve 1995, 18:768.
212. Zaltron S., Puoti M., Liberini P., et al. High prevalence of peripheral neuropathy in hepatitis C infected patients with symptomatic and asymptomatic cryoglobulinemia. Ital. J. Gastroenterol. Hepatol. 1998, 30:391.
213. Zifko U.A., Zipko H.T., Bolton C.F. Clinical and electrophysiological findings in critical illness polyneuropathy. J. Neurol. Sci. 1998, 159:186.
214. Zingraff J., Beyne P., Urena P., et al. Influence of haemodialysis membranes on beta 2-microglobulin kinetics: in vivo and in vitro studies. Nephrol. Dial. Transplant. 1988, 3:284.
215. Zoccali C., Ciccarelli M., Maggiore Q. Defective reflex control of heart rate in dialysis patients: evidence for an afferent autonomic lesion. Clin. Sci. 1982, 63:285.
216. Zochodne D.W., Bolton C.F., Wells G.A., et al. Critical illness polyneuropathy, a complication of sepsis and multiple organ failure. Brain 1987, 110:819.
217. Zochodne D.W., Cheng C. Diabetic peripheral nerves are susceptible to multifocal ischemic damage from endothelin. Brain Res. 1999, 838:11.
218. Zochodne D.W., Cheng C., Sun H. Diabetes increases sciatic nerve susceptibility to endothelin-induced ischemia. Diabetes 1996, 45:627.
219. Zochodne D.W., Ho L.T. Normal blood flow but lower oxygen tension in diabetes of young rats: microenvironment and the influence of sympathectomy. Can. J. Physiol. Pharmacol. 1992, 70:651.
220. Zochodne D.W., Ho L.T., Gross P.M. Acute endoneurial ischemia induced by epineurial endothelin in the rat sciatic nerve. Am. J. Physiol. 1992, 263:H1806.
221. Zochodne D.W., Levy D., Zwiers H., et al. Evidence for nitric oxide and nitric oxide synthase activity in proximal stumps of transected peripheral nerves. Neuroscience 1999, 91:1515.
222. Zochodne D.W., Misra M., Cheng C., Sun H. Inhibition of nitric oxide synthase enhances peripheral nerve regeneration in mice. Neurosci. Lett. 1997, 228:71.
223. Zochodne D.W., Ramsay D.A., Saly V., et al. Acute necrotizing myopathy of intensive care: electrophysiological studies. Muscle Nerve 1994, 17:285.